2374. Predicting the Public Health Impact of Bivalent Vaccines and Nirmatrelvir-Ritonavir against COVID-19

BACKGROUND: Uptake of COVID-19 bivalent vaccines and nirmatrelvir-ritonavir (Paxlovid) remains low across the United States. The goal of this study is to predict the public health impact of increasing uptake of bivalent vaccines and nirmatrelvir-ritonavir in key risk groups on COVID-19 cases, hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hailey J, Tan, Sophia T, León, Tomás M, Jain, Seema, Schechter, Robert, Lo, Nathan C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677765/
http://dx.doi.org/10.1093/ofid/ofad500.1995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677765/
http://dx.doi.org/10.1093/ofid/ofad500.1995

Ejemplares similares